Single-Arm Study of Toripalimab in Combination with Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants (TRANSPARENT)

Protocol No

RTOG-FND-3521-CHS-007-01

Staff Member

Stuart J Wong

Phase

Summary

The purpose of this study is to see if adding toripalimab (immunotherapy) to the usual chemotherapy is the same, better, or worse at keeping your tumor from growing or spreading.

Objective

Study of toripalimab for recurrent metastatic nasopharyngeal carcinoma treatment naive patients

Status

OPEN TO ACCRUAL